News Story: Full Text
Sponsored By
NovoCure Trial
Please Click On The Above Banner For More Details
Braintumor Website


Dianhydrogalactitol (Val-083) synergizes with topoisomerase poisons to overcome DNA repair activity in tumor cells


Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)

 These types of reports bother me because we can't just try them right now.  It seems to make sense, and works in mice but it will be years before most people could try it.  It will unfortunately be too late for most people who currently have a glioblastoma.

However, if our "Promising Pathway Act" was passed, drugs like Val-083 would be approved and easily available, and we could try combining them with a few different topoisomerase drugs, record the outcomes in the registry and quickly learn the best way to use it. This is a much faster pathway to the cure.  We need your help getting it passed. Go to https://virtualtrials.com/activism.cfm for details and to easily send letters to your congresspeople.

 


Posted on: 07/28/2020

Dianhydrogalactitol  (Val-083) synergizes with topoisomerase poisons to overcome DNA repair activity in tumor cells

 




Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740